106 related articles for article (PubMed ID: 1294672)
1. Aerobic and anaerobic bacterial interactions in the development of anaerobic bacterial pneumonia.
Goto J
Kansenshogaku Zasshi; 1992 Dec; 66(12):1660-9. PubMed ID: 1294672
[TBL] [Abstract][Full Text] [Related]
2. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.
Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM
Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of the liver and biliary tract to anaerobic infection in extrahepatic biliary tract obstruction. III. Possible synergistic effect between anaerobic and aerobic bacteria. An experimental study in rabbits.
Lykkegaard Nielsen M; Asnaes S; Justesen T
Scand J Gastroenterol; 1976; 11(3):263-72. PubMed ID: 775613
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
Brook I
J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
Rotstein OD; Kao J
Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
[TBL] [Abstract][Full Text] [Related]
6. Wound infection: a controlled clinical and experimental demonstration of synergy between aerobic (Escherichia coli) and anaerobic (Bacteroides fragilis) bacteria.
Kelly MJ
Ann R Coll Surg Engl; 1980 Jan; 62(1):52-9. PubMed ID: 6987938
[TBL] [Abstract][Full Text] [Related]
7. Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis.
Rotstein OD; Pruett TL; Simmons RL
Arch Surg; 1985 Feb; 120(2):146-51. PubMed ID: 3156575
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic synergy between Escherichia coli and Bacteroides fragilis: studies in an experimental mouse model.
Verweij-van Vught AM; Namavar F; Sparrius M; Vel WA; MacLaren DM
J Med Microbiol; 1985 Jun; 19(3):325-31. PubMed ID: 3892009
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
Rotstein OD; Kao J; Houston K
J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
[TBL] [Abstract][Full Text] [Related]
10. Intravenous injection of mice with bacteroides fragilis and Escherichia coli: role of Thioglycollate medium in the infectious process.
Rodloff AC; Rodloff S; Fischer B; Hahn H
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 May; 254(3):405-12. PubMed ID: 6372324
[TBL] [Abstract][Full Text] [Related]
11. Role of anaerobic bacteria in intra-abdominal septic abscesses in mediating septic control of skeletal muscle glucose oxidation and lactic acidemia.
Vary TC; Siegel JH; Tall B; Morris JG
J Trauma; 1989 Jul; 29(7):1003-13; discussion 1013-4. PubMed ID: 2664200
[TBL] [Abstract][Full Text] [Related]
12. The pathogenicity of Bacteroides fragilis and related species estimated by intracutaneous infection in the guinea-pig.
Maskell JP
J Med Microbiol; 1981 Feb; 14(1):131-40. PubMed ID: 7463462
[TBL] [Abstract][Full Text] [Related]
13. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria.
Wade BH; Kasper DL; Mandell GL
J Antimicrob Chemother; 1983 Oct; 12 Suppl C():51-62. PubMed ID: 6643341
[TBL] [Abstract][Full Text] [Related]
14. The effect of iron on mixed infection of Bacteroides fragilis and Escherichia coli in mice.
Ward CG; Mitchell M; Streitfeld MM
J Surg Res; 1983 Oct; 35(4):351-3. PubMed ID: 6353067
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin- resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique.
Stearne LE; Kooi C; Goessens WH; Bakker-Woudenberg IA; Gyssens IC
Antimicrob Agents Chemother; 2001 Jan; 45(1):243-51. PubMed ID: 11120973
[TBL] [Abstract][Full Text] [Related]
16. Induction of colonic transmural inflammation by Bacteroides fragilis: implication of matrix metalloproteinases.
Medina C; Santana A; Llopis M; Paz-Cabrera MC; Antolín M; Mourelle M; Guarner F; Vilaseca J; Gonzalez C; Salas A; Quintero E; Malagelada JR
Inflamm Bowel Dis; 2005 Feb; 11(2):99-105. PubMed ID: 15677902
[TBL] [Abstract][Full Text] [Related]
17. Experimental aerobic-anaerobic thoracic empyema in the guinea pig.
Mavroudis C; Ganzel BL; Cox SK; Polk HC
Ann Thorac Surg; 1987 Mar; 43(3):298-302. PubMed ID: 3548615
[TBL] [Abstract][Full Text] [Related]
18. Interactions between polymorphonuclear leucocytes, Bacteroides sp, and Escherichia coli: their role in the pathogenesis of mixed infection.
Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
J Clin Pathol; 1986 Apr; 39(4):376-82. PubMed ID: 3517072
[TBL] [Abstract][Full Text] [Related]
19. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of phagocytosis of E. coli by B. fragilis group--an in vitro study.
Beena VK; Kumari N; Shivananda PG
Indian J Pathol Microbiol; 1997 Jul; 40(3):373-6. PubMed ID: 9354011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
